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HOW I DO IT
Left Atrial Appendage Thrombosis and Persistent 
Atrial Fibrillation: combined Treatment with a 
Totally Thoracoscopic Approach
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Abstract
Minimally invasive surgical ablation is generally contraindicated 
in patients with atrial fibrillation and thrombosis of the left atrial 
appendage. 
We have treated three of these patients using an innovative 
technique based on a bilateral video-thoracoscopic approach, 
performing a continuous encircling lesion at the pulmonary 
veins outflow with radio-frequency ablation, simultaneously 
excluding the left atrial appendage. The postoperative course was 
uneventful, without neurologic events and all patients maintained 
a stable sinus rhythm at 1-year follow-up.
This procedure represents a new mini-invasive method to treat 
persistent atrial fibrillation when partial thrombosis of the left 
atrial appendage contraindicates other ablation techniques.
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INTRODUCTION
In patients with persistent atrial fibrillation (AF) and left 
atrial appendage (LAA) thrombosis, current ablation techniques 
are contraindicated[1]. We report a new mini-invasive surgical 
approach that has been shown to be effective in the treatment 
of both AF and LAA thrombosis by restoring sinus rhythm and 
avoiding potentially severe neurological complications. 
TECHNIQUE    
Under general anaesthesia, tracheal intubation is performed to 
allow selective lung ventilation. Transoesophageal echocardiography 
(TEE) monitoring is of paramount importance to confirm or detect 
any LAA thrombus (Figure 1) and is maintained throughout the 
procedure. Then, three port-access sites on the right chest are 
identified: in the 3rd intercostal space (anterior axillary line) for 
the camera and CO2 insufflation and in the 2nd and 5th intercostal 
spaces for instrumentation. In the left hemithorax (mid-axillary 
line), three similar ports are marked.
The left hemithorax is approached through 3 ports using 
12-mm skin incisions. The pericardium is opened and exposed 
with sutures. The base of the LAA is encircled and snared with 
3/0 Prolene Ethibinder (Johnson & Johnson® , New Jersey, USA) 
(Figure 2A), which is an endo-suture system with a pre-assembled 
loop used to stabilize the thrombus. Subsequently, during single 
left lung ventilation, the right hemithorax is approached (Figure 
2B), the pericardium opened and exposed. Blunt dissection with 
Endopeanuts (US Surgical, Norwalk, CT) is performed between 
the superior vena cava and the right superior pulmonary vein, 
reaching the transverse sinus. The oblique sinus is exposed by 
dissecting the inferior vena cava from the right inferior pulmonary 
vein. Two flexible components of the introducer (Atricure Inc., 
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is stabilized by suction, ensuring a temperature-controlled 
use of monopolar and bipolar energy sources. Multiple lesions 
are performed (60 seconds at 70°C each) moving the catheter 
circumferentially to treat all underlying structures. At this stage, 
external electrical cardioversion is performed whenever the sinus 
Mason, OH, USA) are passed through the oblique and transverse 
sinuses around the pulmonary veins and pulled until their 
magnetic tips meet. Then the Atricure Cobra FusionTM ablation 
probe is connected to the introducer and advanced inside the 
chest to create the “box lesion” (Figure 2C); the ablation catheter 
Fig. 2 – A) Base of the left atrial appendage encircled and snared with 3/0 Prolene Ethibinder; B) Operative instrumentation and surgical 
approach; C) Creation of the box lesion around the pulmonary veins; D) Final result after AtriClip implantation at the base of the left atrial 
appendage.
Fig. 1 – A) Intraoperative transesophageal echocardiography showing left atrial thrombus (asterisk); B) Postoperative result with left atrial 
appendage exclusion (arrow).
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rhythm is not regained; any exit block at this stage is assessed 
by pacing the right pulmonary veins. Finally, through the left 
hemithorax, the base of LAA is measured with the dedicated sizer 
and an Atricure AtriClip Pro II is introduced through the most 
caudal port. Under TEE and visual control, the clip is implanted at 
the LAA base (Figure 2D), while exposure is facilitated by gentle 
traction on Ethibinder. The accesses are closed, after partial 
pericardium suturing and chest tubes placement. 
DISCUSSION
Patients with persistent AF are currently treated by various 
ablation techniques with rewarding results[2-4]. However, the 
presence of LAA thrombosis still represents a major issue due to 
the potential risks of systemic embolization once sinus rhythm 
is restored. In this setting, we have adopted a new totally 
thoracoscopic approach that combines initial snaring of the LAA 
base through the left hemithorax, followed by radiofrequency 
ablation after entering the right chest. Three patients with 
persistent AF and LAA thrombosis were treated with this 
approach. Two of them were male and one female, 60, 67 and 
70 years old. The postoperative course was uneventful, without 
neurologic events; all were discharged within one week and 
maintained a stable sinus rhythm at 1-year follow-up. 
Although our experience is limited, we believe that ideal 
candidates should be patients with persistent AF and partial 
LAA thrombosis, which represents a contraindication to both 
endovascular and surgical ablation. The most favourable anatomy 
of LAA for adequate exclusion with an AtriClip is most likely 
represented, in our opinion, by the chicken wing and windsock 
morphological patterns, but we believe that, with increasing 
experience, almost all types of LAA might be successfully treated. 
Furthermore, an important prerequisite is also represented by the 
intra-atrial extension of the thrombus, which should not involve 
the LAA base, preventing the safe application of the snare. 
The presence of thrombus in a fragile structure such as 
LAA requires special care in management and manipulation. 
Stabilization of the thrombus with a temporary closure of the 
LAA base with a 3/0 Prolene Ethibinder loop allowed to achieve 
a box lesion ablation and subsequently allowed to complete 
its exclusion with an AtriClip without removing the loop. The 
efficacy of LAA exclusion by AtriClip implantation has been 
recently validated by angiographic studies[5,6]. Finally, we believe 
that another important issue is represented by the anticoagulant 
regime that should be adopted before the procedure. All of our 
patients where kept on oral anticoagulation with warfarin for at 
least 6 months prior to ablation; we believe that a more prolonged 
treatment (i.e., for more than 12 months) is not advisable since an 
excessive delay in surgical timing could minimize the benefits 
of the procedure leading to persistent AF. Furthermore, we can 
exclude that in the meantime the thrombus has dissolved with 
anticoagulation, which would allow to switch to a transcatheter 
procedure and, after 6 months, we can be reasonably sure that 
the thrombus is more stable within the LAA, reducing the risk of 
fragmentation during the procedure. 
CONCLUSION
The procedure herein described represents a new innovative 
and feasible single-stage mini-invasive method which allows 
to successfully treat persistent AF and simultaneously exclude 
a thrombosed LAA with AtriClip, eliminating the potential risks 
of thrombus fragmentation and migration with possible harmful 
systemic embolization.
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